Sarah Cannon Research Institute
Emma Sturgill, Ph.D. has a diverse work experience in the field of research and medicine. Emma worked at the Sarah Cannon Research Institute from 2019 to the present, starting as a Program Specialist in Personalized Medicine and then progressing to the role of Sr. Program Specialist. Currently, they hold the position of Associate Director in Population Sciences with the institute.
Prior to their work at the Sarah Cannon Research Institute, Emma co-founded PurSolutions LLC in 2015 where they served as the Scientific Director. Emma has also worked as a Postdoctoral Fellow at Vanderbilt University from 2014 to 2016, and beforehand, they were a PhD Candidate at the same university from 2009 to 2014.
Dr. Emma Sturgill obtained their Bachelor of Science degree in Biology and Chemistry from Emory & Henry College, where they attended from 2005 to 2009. Following their undergraduate studies, they pursued their Doctor of Philosophy degree in Cell and Developmental Biology at Vanderbilt University, completing their studies from 2009 to 2014.
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.